Pump.science (RIF, URO)

Overview

Pump.science is a Solana-based protocol that finances decentralized-science research into longevity compounds by gamifying the funding step. It is a spin-off of the memecoin launchpad pump.fun: instead of launching a joke coin, a researcher launches a token that stands for a specific real-world compound, and the trading demand for that token pays for the compound to actually be tested in a lab (Unchained). It launched in November 2024 and its first two experiments, $RIF and $URO, briefly became two of the most-watched tokens in crypto, drawing wide attention to DeSci as a category.

Pump.science matters to a DAO reference because it is the sharpest live example of a funding model the rest of the field treats cautiously: market speculation as the grant committee. Where a research DAO like VitaDAO deliberates over which projects to fund, Pump.science lets an open market decide by buying – and it wires that market directly to a bench experiment.

How a compound becomes a tradeable experiment

The pipeline is deliberately simple. A compound is issued as a token on pump.fun's bonding curve. According to founder Paul Kohlhaas, once a compound's token crosses a $10,000 market cap, "the experiment data is deployed live on Pump Science" – the trading interest has cleared the (very low) bar to fund a real trial, and results then stream back against the token (Unchained). Because a single automated experiment costs on the order of $300, even a modest speculative market can bankroll a full run.

The result is a feedback loop unlike anything in traditional grant funding: attention becomes capital, capital becomes an experiment, and the experiment's data feeds back to the people holding the token. Its critics note the obvious hazard – the same loop rewards hype over rigor, and a compound's token price is not evidence about the compound.

RIF and URO: the first two experiments

$RIF represents rifampicin, an antibiotic being screened for whether it slows aging in model organisms; $URO represents urolithin A, a pomegranate-derived compound studied for cellular "clean-up" (mitophagy). Both launched in November 2024 and spiked violently – on 18 November 2024, RIF's token reached roughly a $227M market cap and URO around $112M, each up tens of thousands of percent over the prior week (Unchained).

Those valuations then fell sharply from their peaks, and the team said it would focus on RIF and URO – running mouse experiments before introducing any new compound tokens, and pausing further launches until security audits of the application and smart contracts were complete (ChainCatcher). The episode is now a standard case study in how a gamified funding mechanism can pull enormous capital and attention into obscure geroscience overnight – and how quickly that attention leaves.

The lab layer: WormBot and FlyBox

What separates Pump.science from a pure memecoin is that the experiments are real and outsourced to specialist labs. Compounds are screened in worms (C. elegans) at Ora Biomedical on its WormBot, and in fruit flies at Tracked Biotechnologies on its FlyBox (Unchained). Ora Biomedical describes the WormBot as a system that “combines robotics, computer vision and machine learning to test thousands of compounds for their effect on lifespan in C. elegans”, and gives its reason for the animal: a lifespan experiment in C. elegans finishes in about three weeks, which is short enough to repeat at library scale (Ora Biomedical, read 21 September 2026).

That page puts numbers on the screen behind Pump.science’s two tokens. Ora reports about 10,000 compounds tested on the platform and roughly 1m observations. In the one library it breaks out, 3,794 distinct treatments across 208 runs produced 4,879 conditions, each normalised to its own control, of which 535 extended median lifespan by 20% or more: an 11% hit rate, at a median gain of 30% among the hits. Alongside it Ora cites DrugAge, the public compendium of published lifespan results, at 1,046 compounds across all 35 species it covers and 700 in C. elegans.

This layer is why holders receive something other than price action: standardized survival-curve data on the compound their token names. It is also the honest limit of the model – worm and fly lifespan screens are early, exploratory signals, several translational steps removed from a human longevity claim.

Tokens, IP rights, and the BIO connection

Pump.science's tokens are pitched as more than speculation: they "represent real-world intellectual property governance rights to the underlying compounds' data and to the experiments being traded" (Unchained). That threads the platform into the wider Molecule / BIO Protocol ecosystem, since founder Paul Kohlhaas leads both. On 25 December 2024, BIO Protocol announced it would airdrop 50 million BIO tokens proportionally to existing RIF and URO holders, pending governance approval to bridge BIO to Solana (Bitget News).

So the token a speculator buys nominally carries a claim on a research asset – a design that borrows the IP-NFT logic Molecule pioneered for VitaDAO, but delivers it through a freely tradeable, meme-launchpad token rather than a deliberative DAO treasury.

Is Pump.science a DAO?

Not in the token-voting sense, and this reference says so plainly – much as it does for ResearchHub. Pump.science is a funding platform and market, not a governed organization: there is no proposal-and-vote treasury steering the protocol, and the decisive mechanism is a price crossing a threshold, not a member vote. Its tokens confer nominal IP-governance rights over specific experiments, but "which compound gets funded" is decided by open-market buying, not by governance.

It earns a place in the DAO-industry directory precisely as the boundary case: the point where DeSci funding stops looking like a DAO and starts looking like a prediction-and-speculation market wired to a lab bench. That makes it the most useful contrast in the BioDAO set for thinking about who should actually control community-funded research.

Where RIF and URO stand now

Both tokens still trade. Read from Dexscreener’s public API on 21 September 2026, against the November 2024 peaks reported at the time:

Each row sums the two Raydium pools that hold almost all of that token: one quoted in SOL, which carries most of the depth, and a smaller one quoted in BIO, opened on 30 June 2025 – the BIO Protocol tie described above, expressed as a trading pair. $RIF’s SOL pool holds about $181,000 and turned over $2,462 in the day to the reading; its BIO pool holds about $18,000 and turned over $1,743, so 9% of the depth carried 41% of the volume.

This page previously recorded a 13 August 2026 reading of the SOL pool alone – 15 buys and 14 sells on about $174 – and concluded that both tokens were dormant. That conclusion no longer holds, and two different things moved. The SOL pool itself went from 29 trades a day to 127 and from a fully diluted value of about $168,000 to $241,000; and the earlier reading counted one of two pools, so the BIO pair’s turnover was missing from it on both dates. About 460 trades a day now cross the four pools, on turnover of roughly $6,600. A single dated snapshot of one venue settles a liveness question no better here than the repository freshness reading on bonding curve settles one there.

The structural risk of speculation-as-grant-committee survives the correction, and is narrower than a dormancy verdict. The funding event is instantaneous and the research is not: a compound’s token clears its threshold, the experiment is commissioned, and the market that commissioned it takes on no further obligation to it. A treasury that raised into the spike keeps the capital; a mechanism that funds each experiment out of live trading demand is left with whatever demand remains. Both tokens sit above the $10,000 market-cap bar the platform uses to commission an experiment, and the nine-figure inflow that made the model famous has gone, so a new compound token would have to raise its own.

The platform itself is still up. pump.science answers behind a Vercel bot checkpoint (HTTP 429 to an automated request, not an outage), so this page’s status reflects the on-chain reading rather than a claim about the site.

How Caper approaches this

Pump.science and Caper sit at opposite poles of one question: how much of a community-funded effort's steering should be for sale. Pump.science makes almost all of it tradeable – a compound gets funded when its freely transferable token clears a market-cap bar, so buying pressure is the allocation mechanism. Caper puts the decisive slice beyond resale: taking part in a caper mints a soulbound, non-transferable proof-of-vote token – earned by casting ranked ballots, and none at all for buying or selling (fractional, and locked to its holder – its deposit authority is the component itself, with updates permanently denied, per contracts/core/src/caper_dao.rs). A member's on-chain weight combines their token holdings with their earned votes, and that same weight sets each member's exit redemption.

The honest read is that each optimizes for something real. Pump.science maximizes liquid, permissionless attention – its whole thesis is that an open market can fund obscure science faster than any committee. Caper's earned, un-sellable weight is built for the opposite case: when you specifically do not want who-decides to be purchasable, and you want the people steering to be the ones who can't simply cash out of the consequences.